Sanofi-Aventis Says Flu Vaccine Protects Against New H5N1 Strains
Posted on: Thursday, 19 October 2006, 09:01 CDT
Sanofi Pasteur has revealed that its vaccine to protect against the H5N1 influenza virus can protect against new strains of the virus, providing wider protection in the event of a pandemic.
Sanofi Pasteur said that the vaccine induces antibodies that neutralize these additional strains which were recently discovered and not included in the original vaccine formulation.
"Improving the repertoire of antibody response is an important goal for pandemic influenza vaccines" said Maria Zambon, deputy director Virus Reference division, Health Protection Agency, UK.
Analysis of blood samples from volunteers who participated in the first phase I clinical trial conducted in 2005 with H5N1 pre-pandemic vaccine showed the potential of the vaccine to protect against recent H5N1 circulating viruses.
On the same day GlaxoSmithKline reported that it had entered an agreement with Switzerland for an advanced purchase agreement if its flu pandemic vaccine. 8 million doses were ordered, enough to cover the entire population.
Sanofi Pasteur has signed contracts with American and certain European governments to distribute the vaccine in the event of a pandemic.
Source: Datamonitor
Related Articles
- Collaborators Study Virulence Of Pandemic H1N1 Virus
- Novavax Reports Positive Preclinical Results for a Novel, Broadly Cross-Protective H5N1 Pandemic Influenza Virus-like Particle (VLP) Vaccine Candidate
- Vietnam Finds H5N1 Virus on Duck Farm
- Vical bird flu vaccine stops H5N1 in animals
- Experts Say Warm Weather Won't Put Lid on H5N1 Virus
- Warmer weather won't put lid on H5N1 virus: experts
- Wild Bird Suspected to Carry H5N1 Virus in HK
- Italy finds mild form of feared H5N1 virus in duck
- Thai Gov't to Vaccinate 150,000 Workers Against Influenza
- Sanofi Pasteur Begins Shipping ADACEL(TM) Vaccine in the U.S. For Combined Protection Against Tetanus, Diphtheria, and Pertussis
 |
 |
User Comments (0)
RSS Feeds